GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AVX-754 | AVX754 | BCH 10618 | BCH10618 | SPD-754 | SPD754
Compound class:
Synthetic organic
Comment: Apricitabine is a nucleoside reverse transcriptase inhibitors (NRTI) class antiretriviral drug that is structurally related to lamivudine and emtricitabine. It is a cytidine derivative.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8759 | apricitabine |
Synonyms ![]() |
| AVX-754 | AVX754 | BCH 10618 | BCH10618 | SPD-754 | SPD754 |
Database Links ![]() |
|
| ChEMBL Ligand | CHEMBL210651 |
| DrugBank Ligand | DB12855 |
| GtoPdb PubChem SID | 483123225 |
| PubChem CID | 455041 |
| Search Google for chemical match using the InChIKey | RYMCFYKJDVMSIR-RNFRBKRXSA-N |
| Search Google for chemicals with the same backbone | RYMCFYKJDVMSIR |
| Search PubMed clinical trials | apricitabine |
| Search PubMed titles | apricitabine |
| Search PubMed titles/abstracts | apricitabine |
| UniChem Compound Search for chemical match using the InChIKey | RYMCFYKJDVMSIR-RNFRBKRXSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | RYMCFYKJDVMSIR-RNFRBKRXSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Apricitabine (links to external site)
Cat. No. HY-14913 |